Assessment of the nature of residual masses at end of treatment in lymphoma patients using volume perfusion computed tomography.

Syha, R; Grünwald, L; Horger, T; Spira, D; Ketelsen, D; Vogel, W; Claussen, C D; Horger, M

Syha, R; Grünwald, L; Horger, T; Spira, D; Ketelsen, D; Vogel, W; Claussen, C D; Horger, M.

Affiliation

Syha R; Department of Diagnostic Radiology, Eberhard Karls University, Hoppe-Seyler-Str.3, 72076, Tübingen, Germany, roland.syha@gmx.net.

Eur Radiol ; 24(3): 770-9, 2014 Mar.

Article in En | MEDLINE | ID: mdl-24306426

Subject(s)

Antineoplastic Combined Chemotherapy Protocols/therapeutic use; Cone-Beam Computed Tomography; Drug Monitoring/methods; Lymphoma/diagnostic imaging; Lymphoma/drug therapy; Adult; Aged; Aged, 80 and over; Blood Volume; Female; Humans; Male; Middle Aged; Neoplasm, Residual; Perfusion Imaging; Prospective Studies; Salvage Therapy/methods; Sensitivity and Specificity

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google

Full text: 1 Database: MEDLINE Main subject: Antineoplastic Combined Chemotherapy Protocols / Drug Monitoring / Cone-Beam Computed Tomography / Lymphoma Type of study: Diagnostic_studies / Observational_studies / Risk_factors_studies Limits: Adult / Aged / Aged80 / Female / Humans / Male / Middle aged Language: En Journal: Eur Radiol Journal subject: RADIOLOGIA Year: 2014 Type: Article

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google